Comparative analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine model.
Saved in:
| Title: | Comparative analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine model. |
|---|---|
| Authors: | Butt H; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD.; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC., Sathish S; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD., London E; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD., Le A; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD., Li Q; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Gudmundsdottir B; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD., Lee DY; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Burke EV; Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD., Yates BP; Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD., Liu DR; Merkin Institute for Transformative Technologies in Healthcare, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA.; Howard Hughes Medical Institute, Harvard University, Cambridge, MA., Hsieh M; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD., Leonard A; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD.; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN., Eaton WA; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Uchida N; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD., Pierciey FJ Jr; Bluebird Bio, Inc, Somerville, MA., Newby GA; Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.; Merkin Institute for Transformative Technologies in Healthcare, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD., Tisdale JF; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD., Demirci S; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD. |
| Source: | Blood advances [Blood Adv] 2026 Jan 27; Vol. 10 (2), pp. 289-300. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41150843 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Comparative analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine model. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Butt+H%22">Butt H</searchLink>; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD.; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Sathish+S%22">Sathish S</searchLink>; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22London+E%22">London E</searchLink>; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Le+A%22">Le A</searchLink>; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Li+Q%22">Li Q</searchLink>; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Gudmundsdottir+B%22">Gudmundsdottir B</searchLink>; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Lee+DY%22">Lee DY</searchLink>; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Burke+EV%22">Burke EV</searchLink>; Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Yates+BP%22">Yates BP</searchLink>; Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Liu+DR%22">Liu DR</searchLink>; Merkin Institute for Transformative Technologies in Healthcare, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA.; Howard Hughes Medical Institute, Harvard University, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Hsieh+M%22">Hsieh M</searchLink>; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Leonard+A%22">Leonard A</searchLink>; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD.; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN.<br /><searchLink fieldCode="AU" term="%22Eaton+WA%22">Eaton WA</searchLink>; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Uchida+N%22">Uchida N</searchLink>; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Pierciey+FJ+Jr%22">Pierciey FJ Jr</searchLink>; Bluebird Bio, Inc, Somerville, MA.<br /><searchLink fieldCode="AU" term="%22Newby+GA%22">Newby GA</searchLink>; Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.; Merkin Institute for Transformative Technologies in Healthcare, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Tisdale+JF%22">Tisdale JF</searchLink>; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Demirci+S%22">Demirci S</searchLink>; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute/National Institutes of Health, Bethesda, MD. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2026 Jan 27; Vol. 10 (2), pp. 289-300. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41150843 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2025017321 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 289 Titles: – TitleFull: Comparative analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine model. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Butt H – PersonEntity: Name: NameFull: Sathish S – PersonEntity: Name: NameFull: London E – PersonEntity: Name: NameFull: Le A – PersonEntity: Name: NameFull: Li Q – PersonEntity: Name: NameFull: Gudmundsdottir B – PersonEntity: Name: NameFull: Lee DY – PersonEntity: Name: NameFull: Burke EV – PersonEntity: Name: NameFull: Yates BP – PersonEntity: Name: NameFull: Liu DR – PersonEntity: Name: NameFull: Hsieh M – PersonEntity: Name: NameFull: Leonard A – PersonEntity: Name: NameFull: Eaton WA – PersonEntity: Name: NameFull: Uchida N – PersonEntity: Name: NameFull: Pierciey FJ Jr – PersonEntity: Name: NameFull: Newby GA – PersonEntity: Name: NameFull: Tisdale JF – PersonEntity: Name: NameFull: Demirci S IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 01 Text: 2026 Jan 27 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 10 – Type: issue Value: 2 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |